Page last updated: 2024-10-30

labetalol and Adenomatosis, Familial Endocrine

labetalol has been researched along with Adenomatosis, Familial Endocrine in 1 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Research Excerpts

ExcerptRelevanceReference
"Oral prazosin was started twenty days before the operation and increased to a maintenance dose of 6 mg per day."1.28[Anesthetic management of a patient with Sipple syndrome]. ( Ishizaki, A; Kim, S; Matsukawa, M; Shiratsuchi, T; Uchiyama, M; Yamamoto, T, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishizaki, A1
Kim, S1
Shiratsuchi, T1
Matsukawa, M1
Uchiyama, M1
Yamamoto, T1

Other Studies

1 other study available for labetalol and Adenomatosis, Familial Endocrine

ArticleYear
[Anesthetic management of a patient with Sipple syndrome].
    Masui. The Japanese journal of anesthesiology, 1991, Volume: 40, Issue:5

    Topics: Administration, Oral; Adult; Anesthesia, Inhalation; Humans; Labetalol; Male; Multiple Endocrine Neo

1991